A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...

AI-driven tumor mapping with Unfold AI helps doctors more accurately assess prostate cancer size, improving treatment success ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...

A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.

Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

Through its vast network of top urologists, oncologists, and researchers from world-class institutions, Human Longevity's $1 ...

Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...